ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,443Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 231

$1.64M Total Retail Price of All Prescriptions

Rank: 1 out of 231

873 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 873 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 873 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 16,172 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
LEVOTHYROXINE SODIUM 777 541 1 3
OMEPRAZOLE 711 415 2 5
AMLODIPINE BESYLATE 607 553 3 4
FUROSEMIDE 603 525 4 6
WARFARIN SODIUM 559 540 5 17
LISINOPRIL 558 440 6 1
SIMVASTATIN 381 227 7 2
METFORMIN HCL 358 212 8 7
DONEPEZIL HCL 356 332 9 26
METOPROLOL TARTRATE 339 267 10 12
RISPERIDONE 332 70 11 34
GABAPENTIN 305 188 12 15
POLYETHYLENE GLYCOL 3350 301 171 13 36
MIRTAZAPINE 299 264 14 25
PRAVASTATIN SODIUM 274 191 15 10
RANITIDINE HCL 274 189 15 51
NITROFURANTOIN MONO-MACRO 273 228 17 76
TRAMADOL HCL 262 172 18 16
TAMSULOSIN HCL 260 179 19 30
TRAZODONE HCL 253 202 20 35
OLANZAPINE 251 168 21 65
SERTRALINE HCL 246 173 22 18
HYDROCHLOROTHIAZIDE 237 168 23 9
CITALOPRAM HBR 236 192 24 20
CARVEDILOL 222 181 25 24
NAMENDA 221 209 26 47
METOPROLOL SUCCINATE 205 175 27 13
LEVETIRACETAM 200 83 28 57
LANTUS 195 167 29 42
ATORVASTATIN CALCIUM 194 167 30 8
QUETIAPINE FUMARATE 191 152 31 39
DIOVAN 188 159 32 27
SULFAMETHOXAZOLE-TRIMETHOPRIM 175 127 33 77
CYMBALTA 173 78 34 46
ATENOLOL 161 144 35 11
ALBUTEROL SULFATE 160 148 36 66
ABILIFY 158 28 37 110
CIPROFLOXACIN HCL 157 137 38 58
CLOPIDOGREL 151 122 39 44
DIVALPROEX SODIUM ER 151 36 39 121
CRESTOR 150 73 41 19
ESCITALOPRAM OXALATE 150 78 41 55
NOVOLOG 150 125 41 72
FLUTICASONE PROPIONATE 148 69 44 40
TOPIRAMATE 144 0 45 156
LIDODERM 143 111 46 78
POTASSIUM CHLORIDE 138 133 47 33
LAMOTRIGINE 138 13 47 159
ADVAIR DISKUS 135 101 49 50
NEXIUM 131 58 50 31
CLONIDINE HCL 128 48 51 63
BACLOFEN 126 0 52 89
ALENDRONATE SODIUM 123 30 53 45
TRICOR 123 45 53 137
ZOLPIDEM TARTRATE 123 94 53 14
BENZTROPINE MESYLATE 121 14 R 56 117
LACTULOSE 121 55 56 84
IBUPROFEN 121 53 56 96
DIGOXIN 117 112 59 80
PLAVIX 117 106 59 60
LEVOFLOXACIN 117 95 59 64
CARBIDOPA-LEVODOPA 115 102 62 73
NYSTATIN 115 74 62 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 72 62 22
METOCLOPRAMIDE HCL 115 73 62 103
PANTOPRAZOLE SODIUM 113 106 66 62
PHENYTOIN SODIUM EXTENDED 109 60 67 119
JANUVIA 105 92 68 93
PROAIR HFA 101 54 69 59
AZITHROMYCIN 99 68 70 32
AMOX TR-POTASSIUM CLAVULANATE 92 66 71 81
LATANOPROST 91 91 72 107
SPIRIVA 90 84 73 61
PREDNISONE 90 63 73 41
ISOSORBIDE MONONITRATE ER 88 82 75 56
KETOCONAZOLE 86 34 76 138
NYSTOP 86 70 76 124
LANTUS SOLOSTAR 85 63 78 90
GLIPIZIDE 85 82 78 71
OXYCODONE-ACETAMINOPHEN 84 47 S2 80 52
LIPITOR 81 53 81 97
ALLOPURINOL 80 46 82 48
DIVALPROEX SODIUM 77 44 83 53
SINGULAIR 77 32 83 109
FLUOXETINE HCL 76 21 85 67
OXCARBAZEPINE 73 0 86 189
CARBAMAZEPINE 73 29 86 150
AMLODIPINE BESYLATE-BENAZEPRIL 72 38 88 94
IPRATROPIUM-ALBUTEROL 71 69 89 68
MELOXICAM 70 51 90 88
DILTIAZEM ER 70 61 90 192
HYDROCODONE-ACETAMINOPHEN 68 49 S3 92 21
SEROQUEL 68 44 92 83
CYCLOBENZAPRINE HCL 68 32 R 92 86
DOXYCYCLINE HYCLATE 67 38 95 98
FAMOTIDINE 67 55 95 148
VENLAFAXINE HCL ER 67 35 95 134
MUPIROCIN 66 27 98 127
TIMOLOL MALEATE 65 50 99 163
EXELON 64 64 100 202
BISOPROLOL-HYDROCHLOROTHIAZIDE 63 60 101 120
CELEBREX 62 60 102 99
TRAVATAN Z 62 32 102 118
AMMONIUM LACTATE 62 35 102 206
AMITIZA 61 41 105 207
ZETIA 60 16 106 125
PAROXETINE HCL 59 31 107 70
PROMETHAZINE HCL 56 26 R 108 112
LEXAPRO 55 31 109 136
MONTELUKAST SODIUM 55 28 109 155
GLIPIZIDE XL 54 54 111 150
PEN NEEDLE 54 13 111 116
PRAMIPEXOLE DIHYDROCHLORIDE 54 51 111 221
DICYCLOMINE HCL 54 23 111 221
GLIMEPIRIDE 53 51 115 38
SUBOXONE 53 0 115 147
FENOFIBRATE 52 11 117 130
DILTIAZEM 24HR CD 51 51 118 144
CLOZAPINE 51 0 118 231
LOVAZA 50 25 120 178
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.